levalbuterol hydrochloride

It is formulated by 8 pharmaceutical companies such as PHARMOBEDIENT, TEVA PHARMS USA, CIPLA and others. It is marketed under 1 brand name, including LEVALBUTEROL HYDROCHLORIDE. Available in 4 different strengths, such as EQ 0.0103% BASE, EQ 0.042% BASE, EQ 0.021% BASE and others, and administered through 1 route including SOLUTION;INHALATION.

Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 8 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...

watch_later Watch: autorenew Loading watch analysis...

rocket_launch Opportunity: autorenew Loading opportunity analysis...

Country

flag

Legal Status

gavel

Expiry From

calendar_today

Expiry To

calendar_today

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength	Route of Administration	Companies	Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

📄

No US Orange Book patents found

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID	Title	Status	Phase	Conditions	Start Date	Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

Filter by Country

CIPLA Total Dosages: 3 Manufacturing Locations: 7

IMPAX LABS INC Total Dosages: 3

LUOXIN AUROVITAS Total Dosages: 4

MANKIND PHARMA Total Dosages: 3 Manufacturing Locations: 2

MYLAN SPECIALITY LP Total Dosages: 1

PHARMOBEDIENT Total Dosages: 3

RITEDOSE CORP Total Dosages: 3 Manufacturing Locations: 1

SUN PHARM Total Dosages: 3 Manufacturing Locations: 21

TEVA PARENTERAL Total Dosages: 1 Manufacturing Locations: 1

TEVA PHARMS USA Total Dosages: 3

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.